R. Duarte (Porto, Portugal), S. Tiberi (London, United Kingdom)
Chemotherapy outcome of pulmonary tuberculosis with mutations in the FN1 and TNXB genes
K. Samsonov (Omsk, Russian Federation), A. Mordyk (Moscow, Russian Federation)
|     |
Genomic analysis of new pre-XDR/XDR cluster of Mycobacterium tuberculosis Beijing genotype emerging in Russia
I. Mokrousov (St. Petersburg, Russian Federation), V. Sinkov (Irkutsk, Russian Federation), P. Khromova (Irkutsk, Russian Federation), A. Gerasimova (St. Petersburg, Russian Federation), E. Chernyaeva (St. Petersburg, Russian Federation), N. Solovieva (St. Petersburg, Russian Federation)
| |
Determination of specific inflammation activity in the presence of the minimal tuberculous changes
T. Tyulkova (Moscow, Russian Federation), N. Khabibullina (Moscow, Russian Federation), S. Skornyakov (Ekaterinburg, Russian Federation), N. Chernavin (Ekaterinburg, Russian Federation), P. Chernavin (Ekaterinburg, Russian Federation)
| |
Higher adverse drug reactions but better completion rate of twelve-dose weekly rifapentine plus isoniazid comparing with nine-month daily isoniazid for latent tuberculosis infection among patients under maintenance dialysis
S. Lin (Taipei, Taiwan), P. Wang (Taipei, Taiwan), J. Feng (Taipei, Taiwan), C. Shu (Taipei, Taiwan)
| |
Diabetic status and the risk of tuberculosis: a nationwide population-based study
J. Yoo (Seoul, Republic of Korea)
| |